Increasing the use of biocompatible,glucose-free peritoneal dialysis solutions
Increasing the use of biocompatible,glucose-free peritoneal dialysis solutions作者机构：Department of Renal Medicine and TransplantationThe Royal London HospitalBarts Health NHS TrustLondon E1 1BBUnited Kingdom Department of Renal Medicine and TransplantationSingapore General HospitalSingapore 169608Singapore
出 版 物：《World Journal of Nephrology》 (世界肾病学杂志（英文版）)
年 卷 期：2015年第4卷第1期
页 面：92-97页
学科分类：12[管理学] 1204[管理学-公共管理] 120402[管理学-社会医学与卫生事业管理(可授管理学、医学学位)] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
主 题：Individualized prescription Biocompatibility Peritoneal dialysis Glucose degradation products Peritonitis Ultrafiltration failure Residual renal function
摘 要：A major concern inhibiting some clinicians from embracing peritoneal dialysis(PD) as the preferred first modality of dialysis is the effects of PD solutions on the peritoneal membrane. These anatomical and functional changes predispose to complications like peritonitis,encapsulating peritoneal sclerosis and ultrafiltration failure. In recent years, biocompatible and glucosesparing PD regimens have been developed to minimize damage to the peritoneal membrane. Can the use of these more expensive solutions be justified on current evidence? In this review of the literature, we explore how we may individualize the prescription of biocompatible PD fluid.
维普期刊数据库